| abstract |
The present invention relates to use of a fixed dose combination comprising an effective amount of Azithromycin or its pharmaceutically acceptable hydrates or salts thereof and an effective amount of Loteprednol or its pharmaceutically acceptable esters or salts thereof for the treatment of ocular infections. The present invention further relates to a pharmaceutical composition comprising fixed dose combination comprising an effective amount of Azithromycin or its pharmaceutically acceptable hydrates or salts thereof and an effective amount of Loteprednol or its pharmaceutically acceptable esters or salts thereof for the treatment of ocular infections. |